In multivariable analysis, the adjusted hazard ratio (HR) of oxygen use was 0.68 (95% confidence interval 0.39–1.17) for death and 0.70 (0.38–1.27) for death at home. Of 433 identified patients with advanced cancer, we enrolled 137 patients (oxygen use, n = 35 no oxygen use, n = 102) who developed low oxygen saturation. Cox proportional hazards regression was used to investigate the effect of oxygen use on overall survival and survival at home, adjusted for systolic blood pressure, decreased level of consciousness, dyspnea, oral intake, performance status, and cardiopulmonary comorbidity. Adult patients in home care with advanced cancer demonstrating first low oxygen saturation (less than 90%) detected in home visits were consecutively included in the study. We conducted a retrospective cohort study at a primary care practice in suburban Tokyo. We aimed to evaluate the association between oxygen use and survival in patients with advanced cancer and low oxygen saturation in home care. The role of oxygen therapy in end-of-life care for patients with advanced cancer is incompletely understood.
0 kommentar(er)
